专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20060205958A1 Direct dianhydride synthesis 有权
标题翻译：直接二酐合成
公开(公告)号：US20060205958A1
公开(公告)日：2006-09-14
申请号：US11078022
申请日：2005-03-11
申请人： Daniel Brunelle , James Cella , Qing Ye , Kwok Chan
发明人： Daniel Brunelle , James Cella , Qing Ye , Kwok Chan
IPC分类号： C07D407/02
CPC分类号： C07C51/367 , C07C65/24
摘要： This invention is related to a method for making diether dianhydrides by the reaction of halophthalic anhydride and a metal salt of an aromatic dihydroxy compound in the presence of a solvent and a phase transfer catalyst. Typical phase transfer catalyst include guanidium salts, aminopyridinium salts, or phosphazenium salts.
摘要翻译：本发明涉及通过卤代邻苯二甲酸酐和芳族二羟基化合物的金属盐在溶剂和相转移催化剂的存在下反应制备二醚二酸酐的方法。典型的相转移催化剂包括胍盐，氨基吡啶鎓盐或磷氮烯基鏻盐。

2. 发明申请

US20070043203A1 Copolyetherimides 有权
标题翻译：共聚酰亚胺
公开(公告)号：US20070043203A1
公开(公告)日：2007-02-22
申请号：US11210164
申请日：2005-08-22
申请人： Qing Ye , David Hall , William Richards , Daniel Brunelle , Havva Acar
发明人： Qing Ye , David Hall , William Richards , Daniel Brunelle , Havva Acar
IPC分类号： C08G69/08
CPC分类号： C08G73/1046 , C08G73/124
摘要： Copolyetherimides compositions having high glass transition temperatures and outstanding ductility are presented. The copolyetherimides having Mw of at least 40,000 comprising isomeric bis(phthalimide) structural units within a relatively narrow range of isomer proportions exhibited Tgs of at least 240° C. and outstanding Notched Izod values. The copolyetherimides comprise oxydianiline residues and structural units of the formulas (I) and (II) (III). The copolyetherimides are characterized by a mole percentage of structural units derived from 4,4′-biphenol in a range from about 55% to about 85% of all bisphenol-derived structural units present in the copolyetherimide composition; a mole percentage of structural units derived from bisphenol A in a range from about 45% to about 15% of all bisphenol-derived structural units present in the copolyetherimide composition; and a total mole percentage of structural units derived from bisphenol A or 4,4′-biphenol of at least 95% of all bisphenol-derived structural units present in the copolyetherimide composition.
摘要翻译：提出了具有高玻璃化转变温度和优异延展性的共聚酰亚胺组合物。具有至少40,000的含有异构双（邻苯二甲酰亚胺）结构单元的异构体双组分（邻苯二甲酰亚胺）结构单元的共聚醚酰亚胺具有至少240℃的Tg和优异的缺口伊佐德值。共聚醚酰亚胺包括氧化二苯胺残基和式（I）和（II）（III）的结构单元。共聚醚酰亚胺的特征在于衍生自4,4'-联苯酚的结构单元的百分比在共聚醚酰亚胺组合物中存在的所有双酚衍生的结构单元的约55％至约85％的范围内; 来自双酚A的结构单元的摩尔百分比在存在于共聚醚酰亚胺组合物中的所有双酚衍生的结构单元的约45％至约15％的范围内; 并且衍生自双酚A或4,4'-联苯酚的结构单元的总摩尔百分比为存在于共聚醚酰亚胺组合物中的所有双酚衍生的结构单元的至少95％。

3. 发明申请

US20060152149A1 Porphyrin compositions 有权
标题翻译：卟啉组合物
公开(公告)号：US20060152149A1
公开(公告)日：2006-07-13
申请号：US11326949
申请日：2006-01-06
申请人： Kyle Litz , James Cella , Qing Ye
发明人： Kyle Litz , James Cella , Qing Ye
IPC分类号： H01J1/62 , C08F230/04 , C07F15/00
CPC分类号： C07D487/22
摘要： Novel metal porphyrin compositions useful as organic phosphors are provided. The novel compositions are prepared from commercially available porphyrin-containing starting materials. In one instance a novel palladium-containing porphyrin composition having a number average molecular weight of greater than 12,000 grams per mole was prepared from 5,10,15,20-tetrakis(3′,5′-di(hydroxy)phenyl)-21H-23H-porphyrin by reaction first with palladium(II) acetylacetonate, followed by reaction with 2-bromo-2-methylpropionyl bromide, and subsequent group transfer reaction of the alpha-bromo ester groups with 9,9-dioctyl-2-vinylfluorene in the presence of CuBr as a radical initiator. The product polymer exhibited a number average molecular weight of 12,884 grams per mole, a weight average molecular weight of 14,338 grams per mole, and a robust red phosphorescent emission. Porphyrin containing copoylmers comprising structural units derived from 9,9-dioctyl-2-vinylfluorene and 9-anthracenylmethyl methacrylate were prepared in a similar fashion.
摘要翻译：提供了可用作有机磷光体的新型金属卟啉组合物。该新型组合物由市售的含卟啉原料制备。在一种情况下，从5,10,15,20-四（3'，5'-二（羟基）苯基）-21H（5'）中制备数均分子量大于12,000克/摩尔的新颖的含钯卟啉组合物 -23H-卟啉通过首先与乙酰丙酮钯（II）反应，随后与2-溴-2-甲基丙酰溴反应，随后将α-溴酯基与9,9-二辛基-2-乙烯基芴的组转移反应存在CuBr作为自由基引发剂。产物聚合物的数均分子量为12,884克/摩尔，重均分子量为14,338克/摩尔，并具有坚固的红色磷光发射。含有衍生自9,9-二辛基-2-乙烯基芴和9-蒽基甲基甲基丙烯酸酯的结构单元的含卟啉的共聚酰基酯以类似的方式制备。

4. 发明申请

US20070215865A1 Opto-electronic devices exhibiting enhanced efficiency 审中-公开
标题翻译：表现出提高效率的光电器件
公开(公告)号：US20070215865A1
公开(公告)日：2007-09-20
申请号：US11384770
申请日：2006-03-20
申请人： Jie Liu , James Cella , Larry Lewis , Anil Duggal , James Spivack , Qing Ye
发明人： Jie Liu , James Cella , Larry Lewis , Anil Duggal , James Spivack , Qing Ye
IPC分类号： H01L51/00 , H01L51/54
CPC分类号： H05B33/14 , H01G9/2004 , H01L51/0037 , H01L51/5032 , H01L51/5231 , Y02E10/542
摘要： Described herein is an organic opto-electronic device comprising a cathode comprising at least one zero-valent metal; an anode; an opto-electronically active organic material; wherein said cathode is in contact with at least one organic phosphonium salt. In certain embodiments, the organic phosphonium salt has structure (I) wherein R1-R4 are independently at each occurrence a C1-C20 aliphatic radical, a C3-C20 cycloaliphatic radical, or a C3-C20 aromatic radical is disclosed and wherein X− is selected from the group consisting of monovalent inorganic anions, monovalent organic anions, polyvalent inorganic anions, polyvalent organic anions, and mixtures thereof.
摘要翻译：本文描述的是一种有机光电子器件，其包括：包含至少一种零价金属的阴极; 阳极; 光电活性有机材料; 其中所述阴极与至少一种有机鏻盐接触。在某些实施方案中，有机鏻盐具有结构（I），其中R 1至R 4各自独立地为C 1 -C 3 20脂肪族基团，C 3 -C 20脂环族基团或C 3 -C 20脂肪族基团， 20芳族基团，其中X - 选自一价无机阴离子，一价有机阴离子，多价无机阴离子，多价有机阴离子及其混合物。

5. 发明申请

US20070215879A1 Opto-electronic devices exhibiting enhanced efficiency 审中-公开
标题翻译：表现出提高效率的光电器件
公开(公告)号：US20070215879A1
公开(公告)日：2007-09-20
申请号：US11384769
申请日：2006-03-20
申请人： Jie Liu , James Cella , Larry Lewis , Anil Duggal , James Spivack , Qing Ye
发明人： Jie Liu , James Cella , Larry Lewis , Anil Duggal , James Spivack , Qing Ye
IPC分类号： H01L33/00 , C09K9/00
CPC分类号： C09K9/02 , C09K2211/1007 , C09K2211/1014 , C09K2211/1044 , H01G9/2059 , H01L51/4206 , H01L51/5032 , H01L51/5221 , Y02E10/542
摘要： Described herein is an organic opto-electronic device comprising a cathode comprising at least one zero-valent metal; an anode; an opto-electronically active organic material; wherein said cathode is in contact with at least one organic ammonium salt. In certain embodiments, the organic ammonium salt has structure (I) wherein R1-R4 are independently at each occurrence a C1-C20 aliphatic radical, a C3-C20 cycloaliphatic radical, or a C3-C20 aromatic radical is disclosed and wherein X+ is selected from the group consisting of monovalent inorganic anions, monovalent organic anions, polyvalent inorganic anions, polyvalent organic anions, and mixtures thereof.
摘要翻译：本文描述的是一种有机光电子器件，其包括：包含至少一种零价金属的阴极; 阳极; 光电活性有机材料; 其中所述阴极与至少一种有机铵盐接触。在某些实施方案中，有机铵盐具有结构（I），其中R 1至R 4各自独立地为C 1 -C 3 20脂肪族基团，C 3 -C 20脂环族基团或C 3 -C 20脂肪族基团， 20芳族基团，其中X +选自一价无机阴离子，一价有机阴离子，多价无机阴离子，多价有机阴离子及其混合物。

6. 外观设计

USD999833S1 Bubble machine 有权
公开(公告)号：USD999833S1
公开(公告)日：2023-09-26
申请号：US29885564
申请日：2023-02-27
申请人： Qing Ye
设计人： Qing Ye
摘要： FIG. 1 is a top perspective view of a bubble machine showing my new design;
FIG. 2 is a bottom perspective view thereof;
FIG. 3 is a right perspective view thereof;
FIG. 4 is a front elevation view thereof;
FIG. 5 is a left side elevation view thereof;
FIG. 6 is a right side elevation view thereof;
FIG. 7 is a top plan view thereof;
FIG. 8 is a bottom plan view thereof;
FIG. 9 is a partial enlarged view of FIG. 4; and,
FIG. 10 is a partial enlarged view of FIG. 8.
Broken lines in the drawings depict portions of the bubble machine that form no part of the claimed design. The additional broken lines surrounding the detail views are for annotative purposes only and form no part thereof.

7. 发明申请

US20120214807A1 COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2 审中-公开
标题翻译：化合物作为CCR2的拮抗剂有用
公开(公告)号：US20120214807A1
公开(公告)日：2012-08-23
申请号：US13281482
申请日：2011-10-26
申请人： Shomir Ghosh , Prakash Raman , Kevin Sprott , Amy M. Elder , Sian Griffiths , Francois Soucy , Qing Ye
发明人： Shomir Ghosh , Prakash Raman , Kevin Sprott , Amy M. Elder , Sian Griffiths , Francois Soucy , Qing Ye
IPC分类号： A61K31/5377 , A61K31/517 , A61K31/435 , A61K31/4725 , A61K31/454 , A61K31/453 , A61K31/4439 , C07D471/04 , C07D405/14 , C07D413/14 , C07D405/04 , C07D409/14 , A61P29/00 , A61P19/02 , A61P25/00 , A61P9/10 , A61P3/10 , A61K31/5025
CPC分类号： C07D401/06 , C07D401/14 , C07D405/06 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/14 , C07D471/04
摘要： The present invention provides compounds of general formula I: or a pharmaceutically acceptable salt thereof, wherein X, n, Y, and R1 are defined generally and in subsets herein. Compounds of the invention are inhibitors of CCR2 and accordingly are useful for the treatment of a variety of inflammatory, allergic, and autoimmune diseases, disorders, or conditions.
摘要翻译：本发明提供通式I的化合物或其药学上可接受的盐，其中X，n，Y和R 1通常在本文中定义并在亚组中。本发明的化合物是CCR2的抑制剂，因此可用于治疗各种炎症，过敏和自身免疫疾病，病症或病症。

8. 发明授权

US08101699B2 Electron-transporting polymers 有权
标题翻译：电子输送聚合物
公开(公告)号：US08101699B2
公开(公告)日：2012-01-24
申请号：US12326115
申请日：2008-12-02
申请人： Qing Ye , Jie Liu , James Anthony Cella , Eisaku Katoh
发明人： Qing Ye , Jie Liu , James Anthony Cella , Eisaku Katoh
IPC分类号： C08F26/06
CPC分类号： C08F12/26 , C08F12/32 , C08F112/14 , H01L51/0003 , H01L51/004 , H01L51/0042 , H01L51/5012
摘要： The invention relates to polymers useful in optoelectronic devices and comprising structural unit of formula I: wherein R1 and R2 are independently at each occurrence, hydrogen, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; R3 is H or alkyl; a and b are, independently at each occurrence 0, or an integer ranging from 1 to 3; and Ar is a direct bond or aryl.
摘要翻译：本发明涉及可用于光电子器件的聚合物，其包含式I的结构单元：其中R 1和R 2在每次出现时独立地为氢，C 1 -C 20脂族基，C 3 -C 20芳族基或C 3 -C 20环脂族基 ; R3是H或烷基; a和b各自独立地为0或1至3的整数; 并且Ar是直接键或芳基。

9. 发明授权

US08062768B2 Compound comprising phenyl pyridine units 有权
标题翻译：包含苯基吡啶单元的化合物
公开(公告)号：US08062768B2
公开(公告)日：2011-11-22
申请号：US12125296
申请日：2008-05-22
申请人： Yangang Liang , Shengxia Liu , Kelly Scott Chichak , Qing Ye , Jie Liu
发明人： Yangang Liang , Shengxia Liu , Kelly Scott Chichak , Qing Ye , Jie Liu
IPC分类号： H01L51/54 , C09K11/06 , C07D213/02 , C07D401/10 , C07D401/14 , C07D405/14
CPC分类号： C07D405/10 , C07D213/06 , C07D213/127 , C07D213/30 , C07D213/643 , C07D401/10 , Y10S428/917
摘要： Organic compounds of formula I may be used in optoelectronic devices wherein R1 is, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; R2 is, independently at each occurrence, a C1-C20 aliphatic radical, a C3-C20 aromatic radical, or a C3-C20 cycloaliphatic radical; a is, independently at each occurrence, an integer ranging from 0-4; b is, independently at each occurrence, an integer ranging from 0-3; Ar1 is a direct bond or heteroaryl, aryl, or alkyl or cycloalkyl; Ar2 is heteroaryl, aryl, or alkyl or cycloalkyl; c is 0, 1 or 2; and n is an integer ranging from 2-4.
摘要翻译：式I的有机化合物可用于光电子器件，其中R 1在每次出现时独立地为C 1 -C 20脂族基，C 3 -C 20芳族基或C 3 -C 20脂环族基; R 2在每次出现时独立地为C 1 -C 20脂族基团，C 3 -C 20芳族基团或C 3 -C 20脂环族基团; a在每次出现时独立地为0-4的整数; b在每次出现时独立地为0-3的整数; Ar1是直接键或杂芳基，芳基或烷基或环烷基; Ar 2是杂芳基，芳基或烷基或环烷基; c为0,1或2; n为2-4的整数。

10. 发明申请

US20110190272A1 CHEMICAL COMPOUNDS 审中-公开
标题翻译：化学化合物
公开(公告)号：US20110190272A1
公开(公告)日：2011-08-04
申请号：US12990711
申请日：2009-05-06
申请人： Kevin Daly , Del Valle David , David Scott , Qing Ye
发明人： Kevin Daly , Del Valle David , David Scott , Qing Ye
IPC分类号： A61K31/551 , C07D237/28 , A61K31/502 , C07D403/12 , C07D401/12 , C07D413/12 , A61K31/5377 , A61P35/00
CPC分类号： C07D403/04 , C07D237/28 , C07D401/04 , C07D417/04 , C07D487/04
摘要： The invention relates to chemical compounds of formula (I): or pharmaceutically acceptable salts thereof which possess CSF-IR kinase inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm-blooded animal such as man.
摘要翻译：本发明涉及具有CSF-1R激酶抑制活性的式（I）化合物或其药学上可接受的盐，因此可用于其抗癌活性，因此可用于治疗人或动物体的方法。本发明还涉及制备所述化合物的方法，含有它们的药物组合物及其在制造用于在温血动物如人中产生抗癌作用的药物中的用途。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式